ASR strikes high-grade gold at depth
Asra Minerals’ drilling has extended gold mineralisation at Gladstone prospect by 45m below previous intercepts, which could increase the resource footprint.
Stockhead
ASX ticks up 0.35pc as gold stocks climb
The ASX 200 has started the day in the green on another uptick in gold prices, driving the gold index up more than 2pc.
TGM’s 2027 gold plans could fuel a re-rate
Theta Gold Mines remains undervalued despite the potential for early gold production from its 6.1Moz Transvaal Gold Mining Estates project.
Long Shortz: Asra Minerals
Asra Minerals has unveiled promising gold hits from ongoing drilling at its Leonora South project in WA.
More Stories
Genetic Signatures’ US push proves harder than expected
Tummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder than expected.
KNB finds gold zone parallel to Sunnyside
Koonenberry Gold’s rock chip sampling returns high-grade assays of up to 14.05g/t gold from an anomaly along the Borah Fault at its Enmore project.
StockTake: Cannindah Resources
Cannindah Resources has identified the potential to substantially increase the amount of copper at its Mt Cannindah project.
ASX climbs 0.32pc in first hour as gold price spikes
The ASX200 has started the day on a positive note, lifted 0.32pc by surging gold prices and strength in resources stocks.
StockTake: Core Energy Minerals
Core Energy Minerals has started aircore drilling at its Cummins uranium project in South Australia.
StockTake: West Coast Silver
West Coast Silver’s latest rock chip and float sampling program has identified high grade silver and elevated copper and gold.
After major setback, Percheron ploughs on
Thanks to a well-timed capital raising ahead of a major setback, Percheron lives on. Can it capitalise on a promising new asset?
Long Shortz: Norfolk Metals
Norfolk Metals has been granted drilling permits for the Carmen project in Chile, hoping to unlock the projects copper potential.
ASX Copper Tier list: Part Two
Part Two of Stockhead’s ASX Copper tier list is here, spotlighting miners, developers, and explorers positioning for international growth.
Alterity targets MSA treatment breakthrough
Alterity Therapeutics is aiming to shift the narrative for patients with Multiple System Atrophy with its lead drug ATH434.
Original URL: https://www.thechronicle.com.au/business/stockhead/page/3